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The efficacy of the use of antibiotics in the treatment of infectious diseases, led to the
general believe that the battle against bacterial pathogens was virtually won. Over
the last years however, it has become apparent that the bacteria are a lot tougher and
"smarter" than was assumed and that this battle is far from over yet. Alarming
reports about infections that do not anymore respond to the available antibiotics
have been coming out of the clinics with increasing frequency (23). It seems that the
rapid evolution-rate of bacteria, combined with the high selective pressure from
excessive (mis)use of antibiotics, has lead to the emergence of several resistance
mechanisms (59). Worse even, the bacteria seem to be spreading their new-found
arms around very efficiently by genetic exchange.
The combined development of different resistance mechanisms and rapid spreading
thereof, have already resulted in pathogens that are multi-resistant. Some of these,
like methicillin resistant Staphylococcus aureus (MRSA) are resistant against all but
one (vancomycin) of the commercially available antibiotics. The biggest threat is
posed by certain Enterococcus strains that cannot be killed anymore by any of the
antibiotics that are applied in the hospitals . This means that in what has been called
the "post-microbial era", people are dying again from infections that were not
considered to be a real health-threat anymore, and "old" diseases like tuberculosis
are starting to become a major problem again.
Over the last decades, the bacteria seem to have developed three main mechanisms
of resistance (27):
i. altered permeability characteristics of the membranes or even active efflux of the
antibiotics by export pumps result in lower and therefore inactive intracellular levels
ii. inactivation of the antibiotic by modification or degradation
iii. less affinity of the target enzymes either caused by mutations or by the
acquisition of a gene for a less vulnerable protein of the same function by genetic
exchange.
Two approaches can be taken in order to deal with the resistance problem. The first
one is trying to block the resistance mechanisms, either by devising better versions
of the currently applied antibiotics or by the design of specific inhibitors of these
resistance mechanisms that can that be applied in combination with current
antibiotics. The second approach is to identify completely new targets and to screen
for or design inhibitors of these targets. For both of these approaches, a detailed
understanding of the molecular basis of the bacterial processes involved is needed.
Certainly the most successful antibiotics of the last decades are the ß-lactams, the
success-story of which began with the discovery of penicillin by Fleming in 1928
(38). The development of resistance however, involving all three types of
mechanisms, now also seems to have put an end to this success-story. Both of the
above mentioned approaches are now being taken to overcome this resistance, based
on detailed knowledge of the target of the ß-lactam antibiotics, which is the
metabolism of peptidoglycan, the key structural component of the bacterial cell wall
Bacterial cell wall structure
After the first observation of bacteria by van Antonie van Leeuwenhoek and his
recognition of their large variety in shapes and sizes, the question as to how these
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unicellular organisms are protected from their environment and how they are able
to maintain a defined shape, has taken a long time to be answered. It was assumed
that bacteria must possess some form of cell wall or exoskeleton but although
numerous attempts were made to isolate these cell walls from bacteria and to
analyze their chemical composition, their nature remained elusive for a long time. It
was not until the technology of electron microscopy became available, that more
detailed information on the structure of the surface of bacteria could be obtained.
Electron microscopic analysis of isolated cell wall preparations revealed the
presence of bag-like structures that were called sacculi (Fig. 1A). Furthermore, it
became apparent that there is a clear distinction between the cell wall morphology
of different bacteria. This distinction was found to correlate with the Gram-
classification that was established based on the staining procedure developed by the
Danish physician Christian Gram in 1884. The cell wall of gram-positive bacteria
proved to be very different from that of gram-negatives and it took some more



































































FIG 1. The bacterial sacculus. Panel A. Electron micrograph of an isolated sacculus.
The magnified inset shows a schematic representation of the arrangement of the
peptidoglycan polymer (159). Panel B. Chemical structure of the peptidoglycan.
The extensive analysis of the composition of the cell wall of gram-positive and gram-
negative bacteria that followed these first observations, resulted in the more or less
clear picture that we have today (100). In gram-positive bacteria, a thick layer of the
material that makes up the sacculus, and is called peptidoglycan or murein, is
located directly on the outside of the cell (Fig. 2). Gram-negative bacteria, however,
possess a second membrane on the outside of the cell and the much thinner
peptidoglycan layer is located in the space between the outer and the inner
membrane, called the periplasmic space. In both cases, the peptidoglycan layer
provides the cell with mechanical stability, allows it to maintain its shape and
uphold a high internal osmotic pressure, which has been described to be about 2-5
atm. for gram-negatives and up to 25 atm. for gram-positives.
Peptidoglycan structure
Of paramount importance to the determination of the exact chemical composition of
the peptidoglycan, was Park's discovery of the peptidoglycan precursor molecules
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and the identification of diaminopimelic acid, muramic acid and D-amino acids as
constituents of the cell wall (reviewed in (136)). Although there is quite some
variation in the precise chemical composition of the peptidoglycan between the
different bacteria, the basic architecture proved to be conserved and is built up of
sugar chains of alternating N -acetylglucosamine and N-acetylmuramic acid
residues, that are cross-linked through peptides carried by the latter sugar (Fig. 1B).
The resulting heteropolymeric macromolecule completely encloses the bacterial cell
and thus functions as a protective casing. The multi-layered peptidoglycan of gram-
positive bacteria, that is located on the outside of the cell, can be up to 10 times as
thick as the peptidoglycan of gram-negative bacteria. It is assumed that the
difference in the thickness of the peptidoglycan layer is the actual basis for the
difference in staining properties in the method developed by Gram. After the exact
thickness of the peptidoglycan layer in gram-negative bacteria had been a matter of
debate for a long time, it was shown that about 75-80% of the peptidoglycan of
Escherichia coli consists of a single layer, which has a thickness of 2.5 nm, and about
20-25 % is triple-layered (99). In contrast to the closely related chitin, peptidoglycan
was shown not to be a crystalline structure, but rather to resemble a viscous gel (97,
148). These gel-like properties are caused by the relative flexibility of the peptide
crosslink, that can be stretched up to four fold from its minimum energy
conformation(98). The sugar strands, that have an average length of 21 disaccharide
units in peptidoglycan from gram-negative bacteria (58) but which are generally
longer in peptidoglycan of gram-positive origin, are thought to be arranged in a
helical way with 4 to 5 disaccharide units per turn. In the largely single-layered
gram-negative peptidoglycan, this arrangement allows a lower degree of
crosslinking (20-50%), than in multi-layered gram-positive peptidoglycan in which
up to 90% crosslinking has been observed (100).
A considerable amount of information on the exact composition of the
peptidoglycan of different bacteria has been acquired over the last couple of years,
using an HPLC analysis method that was established by Glauner and which has
become an invaluable tool for peptidoglycan-related research (45). Using this
method, the peptidoglycan could be shown to be a very dynamic structure, the
composition of which is highly variable and dependent on the physiological state of
the bacterium (46, 47).
Gram-negative cell wall architecture
Apart from inherent structural distinctions between the peptidoglycan of gram-
positive and gram-negative bacteria, also its interaction with the other constituents
of the bacterial envelope differs (see Fig. 2). The thin layer of gram-negative
peptidoglycan is associated with the outer membrane. This interaction is mediated
through Braun’s lipoprotein (14). This small structural protein carries a lipid anchor
on its N-terminus, through which it is attached to the membrane, and it is covalently
bound to the peptidoglycan at its C-terminus. Other membrane-bound lipoproteins,
such as the peptidoglycan associated lipoprotein (Pal), have also been described to
tightly bind to the peptidoglycan through non-covalent interactions (101). A
conserved domain was proposed to be involved in this peptidoglycan binding (28).
This domain is also present in the OmpA outer membrane protein, for which tight
interactions with the peptidoglycan have been described. These interactions seem to
result in a tight connection between the peptidoglycan and the outer membrane as
was observed in early electron microscopy studies. However, new methodology in
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electron microscopy led to the concept of a periplasmic gel, in which a hydrated
peptidoglycan occupies the total volume of the periplasmic space (64). This concept





















FIG. 2. schematic representation of the cell envelope of gram-positive bacteria (left
side) and gram-negative bacteria (right side). The major constituents are indicated.
More variable features such as S-layers and capsules are not shown (13).
An even more controversial issue is the presence of the so-called adhesion sites.
These sites were first described by Bayer as regions where contact between the outer
and inner membrane was preserved after plasmolysis (4). The existence of these sites
has been challenged though (85), and the possible contribution of the peptidoglycan
to this phenomenon is unknown (5). Another type of adhesion between the outer
and inner membrane that was hypothesized are the periseptal annuli. These annuli
are proposed to represent future sites of division, and the contact of the membranes
at these sites supposedly seals of a part of the periplasmic space. The membrane
fraction of intermediate density that is thought to represent these sites, was shown
to contain components of the peptidoglycan synthetic machinery (74).
Lately, the existence of several types of cross-envelope transport systems has been
described to be present in various gram-negative bacteria (129). These multi-
component systems are involved in the transport of macromolecular ligands, such as
proteins of DNA, and are thought to span the entire periplasmic space. The issue of
the penetration of the peptidoglycan layer by these systems has so far been ignored,
and is the subject of Chapter 7 of this thesis.
Gram-positive cell wall
In gram-positive bacteria, the peptidoglycan layer is located outside the cell and
therefore the transport of proteins over the cytoplasmic membrane was long
considered to be synonymous with export. Recently, it was shown though that
several proteins are retained between the peptidoglycan layer and the membrane,
leading to the concept of gram-positive periplasm (112). This observation should not
come as too big a surprise, as the highly crosslinked gram-positive peptidoglycan
was expected to act as a permeability barrier for larger proteins, based on
measurements of the sieving characteristics of gram-positive peptidoglycan . The
presence of (lipo)teichoic acids that tightly associate with cell wall of gram-positive
bacteria renders this wall even more impermeable. Nevertheless, several proteins
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have been shown to be transported through the gram-positive wall, and specific
association mechanism have been described for proteins that are to be retained in
the wall or displayed on the surface. The most ingenious of these systems involves
the covalent linking to the peptidoglycan of proteins that display a specific signal
sequence (138). The machinery which is involved in this cell-wall sorting mechanism
has not been identified yet. Other systems involve the non-covalent binding of
proteins to peptidoglycan or teichoic acids, and the domains that are thought to be
involved in this binding often show the presence of repeat sequences (79).
Peptidoglycan metabolism
Although the polymeric structure of the peptidoglycan and its context in the cell-
wall differs dramatically between gram-negative and gram-positive bacteria, the
primary structure is quite conserved. This conservation is reflected in the
biosynthetic machinery. Most of the initial information on this machinery originated
from the attempts to elucidate the mechanism of action of antibiotics that interfered
with one or more steps of the peptidoglycan metabolism. The biosynthetic route that
leads to the formation of the peptidoglycan polymer has been elucidated completely
in E. coli and is schematically depicted in figure 3A (for a review see (158)). It
involves the activity of a large number of cytoplasmic and membrane bound
enzymes. The genes encoding these enzymes have all been cloned and sequenced,
and were found to be located in two clusters of genes on the E. coli chromosome,
denoted mra and mrb.
The biosynthetic pathway can be divided in three stages. The first stage is the well
characterized synthesis of the precursor molecules in the cytoplasm. This part of the
biosynthesis involves the generation of N -acetylmuramic acid from N -
acetylglucosamine, followed by the step-wise addition of 5 amino acids, the majority
of which is specific for bacteria. This addition is mediated by t-RNA independent
amino acid ligases. As these reactions have no counterpart in humans, this early part
of the peptidoglycan biosynthetic pathway is already interesting from an
antibacterial point of view. Two established antibiotics are inhibitors of these early
steps: cycloserine that inhibits the racemase that is responsible for the formation of
D-alanine, and phosphonomycin that inhibits the transfer of phosphoenolpyruvate
to UDP-N-acetylglucosamine. Apart form these two inhibitors, the precursor
synthesis has not been fully exploited as an antibacterial target and therefore the
enzymes involved therein currently receive a lot of attention from both academic
and industrial researchers.
The nucleotide-activated N-acetylmuramylpentapeptide (Fig. 3) that is the product
of the cytoplasmic stage, is then linked to a lipid carrier, followed by the addition of
an N-acetylglucosamine (NAG) residue and transport over the membrane. Less
information is available on this second stage, which takes place in the membrane.
Also the enzymes involved in these steps are the targets of inhibitors such as
tunicamycin, which blocks the addition of the NAG (a reaction that is not specific for
bacteria though), and bacitracin, which inhibits recycling of the undecaprenol lipid
carrier.
After having been transferred to the outer side of the cytoplasmic membrane, the
lipid linked precursors serve as substrates for the polymerization reaction. This final
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stage of the peptidoglycan synthesis has received most attention over the years, as it



































































































FIG. 3. Biosynthesis of the peptidoglycan precursor. The reactions that take place
in the first two stages of the pathway shown. The steps that are the target of
inhibition by specific antibiotics are indicated. The inset shows the structure of
UDP-N-acetylmuramyl-pentapeptide.
Penicillin binding proteins
Although the people of ancient China and Egypt were supposedly already using
moulded bread for the treatment of infected wounds (52), Fleming's serendipitous
discovery of the antibacterial activity of a colony of Penicillium notatum against
Staphylococci, fully disclosed the potential of antibiotic substances to mankind (38).
It took almost 30 years to unravel the principle of the antibacterial action of the ß-
lactam antibiotics, of which penicillin is the archetype. Park and Strominger
reported that penicillin inhibits the final steps of cell wall biosynthesis (123). By the
use of radiolabeled penicillin it had been show that the target-enzymes bind their
inhibitor covalently, and therefore they were called penicillin binding proteins
(PBPs). An elegant assay, that involves the separation of radiolabeled PBPs by SDS-
polyacrylamide gel electrophoresis, allowed the determination of the number and
sizes of the PBPs in different bacteria (141). In E. coli, 9 PBPs (PBP 1A, 1B, 2, 3, 4, 5, 6,
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7 and 8) could be detected by this method (for a review see (44)). However, it was
reported recently that PBP8 is, in fact, an degradation product of PBP7 caused by the
proteolytic cleavage of PBP7 by OmpT (62). With the recent cloning of the gene for
PBP7 it was assumed that all PBP-encoding genes had been identified (63). This
assumption was proved wrong though by the identification of an additional PBP-
encoding gene from E. coli genomic sequence. The size of this new PBP corresponds
to that of PBP6 and therefore it may not have been detected before.
The PBPs have been divided into two classes based on their molecular weight: the
high molecular weight PBPs 1A, 1B, 2 and 3 and the low molecular weight PBPs 4, 5,
6 and 7. This division also reflects a functional difference as the high-MW-PBPs are
involved in the synthesis of the peptidoglycan, whereas the low-MW-PBP’s function
as hydrolases (see below). Both classes of enzymes recognize as a substrate the
terminal D-alanyl-D-alanine of the pentapeptide carried by the peptidoglycan
subunits. In the case of the high-MW-PBPs, the terminal D-Ala is cleaved off,
resulting in the formation of a covalent enzyme-substrate complex in which the
active site serine is acylated. The bound tetra-peptide is trans-acylated to the meso-
diaminopimelic acid residue of a receptor peptide. This transpeptidation reaction
thus causes the formation of a peptide crosslink in the peptidoglycan polymer. In
the case of the low-MW-PBPs the acylated enzyme is deacylated by a water
molecule explaining the carboxypeptidase activity or, in the case that a D-Ala-m-Dap
cross-bridge is the substrate, endopeptidase activity is displayed by these enzymes.
The high-MW-PBPs 1A and 1B (often referred to as class A high-MW-PBPs) combine
the transpeptidation activity with a glycosyltransferase activity that resides in the N-
terminal domain of these proteins. This activity is responsible for the polymerization
of the glycan strands and as such PBP1A and 1B are described to be the main
peptidoglycan synthesizing activities. Although E. coli can cope with losing either
one of them, the deletion of both genes, ponA and ponB, is lethal to the cells. This
suggests that both enzymes are able to substitute for each other and that the
presence of two enzymes reflects a back-up mechanism. The other (class B) high-
MW-PBPs 2 and 3 were also assumed to possess a glycosyltransfer domain, even
though their N-terminal domains do not show homology to that of the class A PBPs.
Glycosyltransfer activity of the class B PBPs has never been proven convincingly
though. As the peptidoglycan synthesizing activity of PBP2 was described to
depend on the presence of the RodA protein (75), it has been postulated that the
proposed glycosyltransferase activity of PBP2 and 3 is actually derived from
accessory proteins.
The synthesis of the glycan strands in gram-positive bacteria was described not only
to be mediated through homologues of the class A PBPs, but additional non-
penicillin binding proteins were reported to be responsible for a large fraction of the
glycosyltransferase activity (124). In E. coli, the presence of one penicillin-insensitive
glycosyltransfer activity has been reported, and recently a number of genes coding
for homologues of the glycosyltransferase domain of the class A high-MW-PBPs
were identified from genomic sequence. The activity of one of these homologues
could be demonstrated in our laboratory recently (29). Although the
glycosyltransferase activity also provides an excellent antibacterial target, no specific
inhibitors have been developed so far. The only inhibitor that is clinically used is
vancomycin, a glycopeptide that binds to the terminal D-Ala-D-Ala of the stem
peptide and as such directly inhibits the transpeptidase activity. The binding of this
large molecule also seems to sterically influence the glycosyltransferase reaction. A
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specific inhibitor of the glycosyltransferases has been isolated, but this inhibitor,
called moenomycin or flavomycin, is only used as a feed additive as its
pharmacokinetic properties made it unsuited for use in humans.
The inhibitory properties of penicillin and other b -lactam antibiotics were proposed
to reside in their potential to mimic the D-Ala-D-Alanyl moiety of the peptide side-
chain (149) (Fig. 4). In this model, the position of the reactive lactam bond
corresponds to that of the scissile D-Ala-D-Ala peptide bond, resulting in opening of
the ß-lactam ring and acylation of the protein. The low deacylation rate of the





































FIG. 4. Proposed mechanism for b -lactam action. The b -lactam ring mimics the
conformation of the terminal D-Ala-D-Ala of the peptide side chain carried by the
growing glycan strand.
ß-lactam resistance
Already a few years after the first clinical use of penicillin, bacterial strains were
found that displayed resistance. These strains were shown to inactivate penicillin by
a specific ß-lactamase activity. In fact, the enzyme that was responsible for this
activity turned out to be a close relative of the PBPs, the main difference being that
the deacylation rate of this enzyme proved to be much higher and therefore the ß-
lactams are rapidly hydrolyzed (41). The identification of new classes of ß-lactams,
combined with chemical modification, resulted in the development of a large
spectrum of semisynthetic ß-lactam antibiotics, and proved to be an efficient means
of conquering the resistance development. Over the last years, it has however
become apparent that the bacteria have rapidly caught up and other mechanisms of
resistance have appeared. One of the most efficient of these mechanisms is the
acquisition of genes that code for additional PBPs that have a low affinity for ß-
lactams. This has been shown to be the case for methicillin resistant S. aureus
(MRSA) (9). Also changes in membrane permeability and even the occurrence of
transport systems that actively export ß-lactams are contributing to the development
of resistance. As empirical chemical modification does not seem to result in
compounds that can evade these resistance mechanisms anymore, structure-based
approaches have been initiated that are focused at the design of better tailored
inhibitors. So far these approaches have been aimed at finding ß-lactamase
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inhibitors mainly, as for several of these the structures are available. The structure-
based design of inhibitors of resistant PBPs has long been hampered by the lack of
structural information. The recent elucidation of the structure of a resistant PBP,
PBP2x of Streptococcus pneumoniae, is therefore a pivotal step towards the design of
future generations of PBP-inhibiting compounds (121).
Growth of the sacculus
Although the biochemical steps involved in the biosynthesis of peptidoglycan are
well understood, the actual process of incorporation of newly synthesized material
into the sacculus is less so. Growth of the sacculus not only involves the generation
of new bonds but also the hydrolysis of old ones. In the case of gram-positive
bacteria, newly synthesized glycan strands are thought to be incorporated in a
random way rather than in discrete growth zones (128). After the incorporation on
the cytoplasmic side of the wall the new strands are thought to be pulled into the
peptidoglycan by the hydrolysis of bonds in layers above them. This type of
incorporation will result in an inside-to-outside growth of the peptidoglycan layer
and a role for specific hydrolases that only cut bonds that are under stress has been
proposed for this model (88).
In gram-negative bacteria the situation is much more complicated, as the largely
single-layered peptidoglycan is more vulnerable than the multilayered gram-
positive peptidoglycan. Local weakening of this layer during the incorporation of
new material, could have disastrous effects for the cell. The insertion of new
peptidoglycan during growth of the sacculus cannot be imagined to occur without
the concomitant hydrolysis of bonds in the polymer though. Several models, which
are summarized below, have been proposed to account for the ability of gram-
negative bacteria to enlarge their sacculus without affecting the integrity of the
stress-bearing peptidoglycan layer.
The terminal D-Ala of the peptide side-chains is rapidly removed by the action of
carboxypeptidases, once the strand has been incorporated in the polymer. As a
result, the free peptides of "old" peptidoglycan can only function as acceptors in the
transpeptidation reaction that forms crosslinks with a newly synthesized strand. The
donor peptide and acceptor peptide in a crosslink can be chemically distinguished,
due to the presence of a free e -amino group on the diaminopimelic acid residue of
the latter. Therefore, the ratio of the amount of radioactivity that ends up in donor or
acceptor peptides after a pulse chase labeling experiment with 3H-dap, can be
determined. This ratio, called the acceptor-donor radioactivity ratio, can be used to
get information on the mode of incorporation of newly synthesized peptidoglycan
into the old layer. Using this elegant method, Burman and Park concluded that the
newly synthesized strands are incorporated pairwise, indicated by the relatively
high amount of radioactivity in acceptor peptides (19). He proposed this
incorporation to be established in a make-before-break way, i.e. the new stand are
first covalently attached to the old strands before the bonds between the latter are
broken.
Based on the detection of multimeric muropeptides in the peptidoglycan of E. coli by
Glauner, combined with the results form pulse-chase experiments, Höltje and
Glauner proposed that the new peptidoglycan is incorporated in a patch-like fashion
and that the presence of multimeric crosslinks serves as a signal for specific
hydrolases (67). This signaling is also a key feature of an adapted version of the
patches model that was recently proposed by Höltje and has become known as the
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three-for-one model (65). In his model, the multimeric crosslinks would indicate that
a new set of three glycan strands has been hooked up underneath the strand that is
to be removed. The crosslinks are than split and the old strand is removed, resulting
in the three new strands being pulled into the stress-bearing layer.
Yet another model was proposed by Norris who postulated that the peptidoglycan
synthesis machinery is regulated by local changes in membrane morphology (118).
When peptidoglycan hydrolase activity has caused the formation of a weak spot,
this would cause the membrane to start bulging out, due to the high internal osmotic
pressure. This local hernia would then induce peptidoglycan synthesis, thus
patching the weak spot and causing an increase in the overall surface of the layer.
Although all of these models are very elegant and all are supported by several lines
of evidence, none of them has been definitely proven so far. One aspect that is
common between these models though, is the involvement of specific peptidoglycan
hydrolases.
Peptidoglycan hydrolases
The first enzyme that was shown to degrade bacterial cell walls was identified by
Alexander Fleming, and was called lysozyme for its ability to cause lysis of bacterial
cells. This enzyme was shown to be omnipresent in nature and to have an important
role in the host-defense mechanism of animals and plants. Also numerous
bacteriophages encode lysozymes, causing lysis of the host during the final step of
infection.
Bacteriolysis can also be observed without any exogenous enzymes being present,
when bacteria were exposed to certain unnatural growth conditions. This so-called
autolysis was thought to be mediated by endogenous enzymes that were able to
hydrolyze bonds in the peptidoglycan layer and were therefore called autolysins. It
became clear that, in fact, the induction of autolysis also is the active principle of the
antibiotics that are directed against the peptidoglycan metabolism, such as the ß-
lactams. This important aspect of the antibacterial action of ß-lactams antibiotics has
often been overlooked, and is underscored by the observations that tolerance to
these antibiotics is caused by a reduction in autolytic activity (55, 86, 150).
Although the interaction of the ß-lactams with the peptidoglycan synthetic
machinery is well-established, the precise mechanisms that are involved in the
induction of autolysis are not clear. Autolysis induced by treatment with certain
chemicals, such as EDTA or ethanol, or exposure to repeated osmotic shock is
thought to be based on a more general disturbance of the envelope structure (103,
104). This type of induction may also explain the recruitment of the host cell
autolytic system by certain phages, such as bacteriophage MS2 (162). These phages
do not encode their own lysozymes but rather encode proteins of which the
insertion in the envelope induces the host autolysins. The autolysis as induced by a
nutritional deficiency or by inhibition of the peptidoglycan-synthesizing machinery
by specific inhibitors, probably involves more complex regulatory mechanisms. It
was proposed that the main mechanism may be a general disturbance of the balance
between peptidoglycan synthesis and peptidoglycan hydrolysis (165). As described
in the above section, growth of the bacterial sacculus is supposed to involve a
balanced interplay of peptidoglycan synthesizing and hydrolyzing activities, the
latter having been proposed to function in the creation of new acceptor sites and in
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the incorporation of new peptidoglycan as described in the make-before-break and
three-for-one model. An inhibition of the synthetic enzymes would result in an
unbalanced activity of the hydrolases. However, this implies that the enzymes that
are responsible for autolysis are identical to the ones that are involved in growth of
the sacculus. This assumption is refuted by the observation that autolysin deficient
mutants still are able to grow normally. Rather, the enzymes responsible for
autolysis seem to have a function in the splitting of the septum which under normal
circumstances marks the end of cell-division. This hypothesis is derived from the
observation that autolysis deficient mutants of S. pneumoniae show a defect in cell-
separation (137). Furthermore, the analysis of the lysis characteristics of E. coli also
suggests a specific triggering of the peptidoglycan hydrolysis at the site of division
(89).
Over the years, numerous peptidoglycan hydrolases have been identified in several
bacterial species, displaying specificities for almost every bond in the peptidoglycan
polymer. As it is hard to imagine that autolysis is a physiological relevant function,
the precise role of most of these enzymes is still unclear.
Gram-positive hydrolases
The major autolysin of Streptococcus pneumoniae was one of the first peptidoglycan
hydrolases to be identified and has been studied extensively (115). The enzyme
proved to be an amidase, that splits the bond between the peptide moiety and the N-
acetylmuramic acid residue (see Fig. 4). The export from the cytoplasm and the
activation of this protein are dependent on the presence of lipoteichoic acids and the
enzyme was shown to bind specifically to the choline residues of these molecules
(70). These choline-binding properties reside within a specific domain that displays
the presence of characteristic sequence repeats. These repeats have also been
described to be present in other non-hydrolase peptidoglycan associated proteins. It
therefore seems that the built-up of this enzyme is modular with a hydrolase
domain being fused to a peptidoglycan anchoring domain. A deletion in the lytA
gene, coding for the major autolysin was shown not to be lethal for the cells (137).
The main effect of this deletion proved to be an impaired cell-separation, suggesting
a role for this enzyme in cell division. Furthermore, a lytA deletion caused a
tolerance to ß-lactam antibiotics. When the lytA gene was inactivated in a capsulated
virulent strain, the ability to export the main virulence factor, pneumolysin, was
affected, suggesting an additional role for the autolysin in protein export (10). Apart
from the autolytic amidase, a glucosaminidase activity that is also choline
dependent has been described to be present in S. pneumoniae (43).
Another gram-positive hydrolase system that has been well-studied is that of
Enterococcus hirae (139). This bacterium contains two muramidase activities of which
the precise function is currently unknown but that also have been implicated in cell
separation. Although these muramidases split the same bond as lysozyme, no
obvious relation between these enzymes and lysozyme has been shown. Rather the
muramidase-2 sequence proved to be very homologous to that of the major
autolysins of Lactococcus lactis and Streptococcus faecalis (8, 18). The genes coding for
the latter two have been identified by making use of the ability of autolytic enzymes
to digest gram-positive cell walls, incorporated in agar plates. This allows the rapid
screening of a genomic library for the expression of autolysin genes. Another
powerful tool that puts this cell-wall clearing property of gram-positive autolysins
to use, is zymogram technology, which involves the incorporation of cell walls in the
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polyacrylamide matrix of an SDS-polyacrylamide electrophoresis (PAGE) gel (102).
After electrophoresis, the proteins are allowed to renature in-gel and regain activity.
Autolytic activity can afterwards be readily detected by the appearance of cleared
zones in the gel. This technology has thus far been mainly used for the analysis of
gram-positive bacteria because the thickness of the cell wall makes it relatively easy
to obtain enough substrate to incorporate in the gel, and even commercially
available lyophilized Micrococcus cells can be directly used for this purpose. It was in
particular the work of Foster that showed the power of zymogram technology in the
study of the Bacillus autolysins (39).
A whole range of autolysins have been reported to be present in Bacillus subtilis and
other Bacilli (139). Although the precise functions of these enzymes are not known,
some of them are considered to be involved in the sporulation process. Autolytic
activity in B. subtilis seems to be the subject of complex regulation and different
processes such as the production of degradative enzymes, the development of
competence and flagellation seem to be linked to the levels of autolytic
peptidoglycan hydrolases (3, 36).
Recently a bifunctional peptidoglycan hydrolase has been cloned from S. aureus
(120). The atl gene was found to encode both an N-acetylglucosaminidase and an
amidase and after translation these activities are separated by proteolytical cleavage.
The resulting enzymes seem to function in cell separation. Inactivation of the gene
showed that additional bands that had been detected on zymogram also
disappeared and therefore most likely do not represent additional autolysins (40).
Other strains of Staphylococcus have been shown to possess a peptidoglycan
hydrolase, called lysostaphin, that is specific for the pentaglycine bridges that
crosslink the peptide side-chains in staphylococcal peptidoglycan (130).
Gram-negative hydrolases
In contrast to the large amount of information that is available on the peptidoglycan
hydrolase of gram-positive bacteria, the only gram-negative bacterium for which the
peptidoglycan hydrolase system has been studied in detail is E. coli. This system
proved to be very complex and to involve a large number of hydrolases of different
specificity (Fig. 4). The presence in E. coli of peptidoglycan hydrolase activities was
already described in the early sixties (126), and over the years the individual
activities were characterized and the corresponding genes cloned. When the work
described in this thesis was started, 11 peptidoglycan hydrolases had been
identified, which already was considered to be a remarkably high number.
However, the last few years have seen the addition to this list of an endopeptidase:
PBP7 (131), an L,D-carboxypeptidase (156), a cytoplasmic amidase: AmpD (68), and
three lytic transglycosylases (this work). Genetic evidence further suggests the
presence of another amidase (our unpublished observations), a putative
carboxypeptidase: PBP6, and two more lytic transglycosylases. So without even
taking into account the four (!) recently identified lysostaphin homologues (see
Chapter 5), the total number of enzymes that hydrolyze bonds in the peptidoglycan
adds up to 21 (Table 1). The presence of such a broad array of peptidoglycan
hydrolytic activities is very puzzling, especially in light of the fact that for the
majority of these enzymes there is no clue as to their physiological function.
A clear distinction has to be made between enzymes that hydrolyze bonds in the
peptidoglycan and true autolysins. The carboxypeptidases belong to the former
group as do two of the amidases and the N-acetylglucosaminidase. As described
General introduction 15
above, the D,D-carboxypeptidases PBP5 and PBP6 remove the terminal alanine from
the stem peptide (although a recent study failed to confirm this activity for PBP6
(157)). These enzymes have been proposed to regulate the degree of crosslinking, yet
they are not essential (15).
An L,D-carboxypeptidase has been purified to homogeneity recently (156). This
enzyme, which is the target of norcadicin removes the second D-Ala resulting in the
formation of a tripeptide. Similar activities of different molecular weight have been
described before, and the exact number of L,D-carboxypeptidases that is present in E.
coli is unclear (7, 114). The genes coding for none of the activities has been cloned
yet.
The periplasmic amidase AmiA was reported to only accept low molecular weight
muropeptides as a substrate as is also true for the N-acetylglucosaminidase and the
AmpD amidase (68, 125, 166). These enzymes are therefore probably involved in
recycling of the peptidoglycan (see below).
E. coli autolysins
The true autolytic system of E. coli is composed of endopeptidases and lytic
transglycosylases. Recently the identification of a putative amidase was described,
which, based on the effects of overproduction of this protein, could be an genuine
autolysin (153). The peptidoglycan hydrolytic activity of this enzyme remains to be
proven though.






























N-acetylglucosaminidase N-acetylmuramidase (lytic transglycosylase)
FIG. 4. Specificities of the peptidoglycan hydrolases of E. coli. The bond that is
cleaved by the individual enzymes is indicated by an arrow.
Three different autolytic endopeptidases have been described in E. coli, two of which
are penicillin binding proteins: PBP4 and PBP7. PBP4, has been shown to act as an
endopeptidase both in vitro and in vivo (91). Overproduction of the dacB gene,
encoding PBP4, resulted in a decrease in crosslinking. Based on the observation that
the specific activity of PBP4 is increased just before cell-separation, suggesting a
possible role of this protein in cell division (53). The demonstration of the
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endopeptidase activity of PBP7 and the cloning of its gene have only been only
reported recently (63). The endopeptidase activity was surprisingly found to be
limited to polymeric peptidoglycan whereas the crosslinks of isolated muropeptides
do not serve as a substrate (131). PBP7 has been described to have high affinity for
the penem antibiotics, which are able to induce lysis in non-growing bacteria that
are resistant to the effects of other ß-lactams (154). The elucidation of the function of
PBP7 may therefore be very rewarding from an antibacterial point of view.
A penicillin insensitive endopeptidase was found to be encoded by the mepA gene
(83). This enzyme is able to cleave both the main dap-D-Ala crosslinks and the dap-
dap crosslinks, that were identified by Glauner and constitute only a small but
structurally important fraction of total crosslinks (46). The mepA gene was described
not to be essential and the MepA protein was discussed to be involved in
peptidoglycan turnover (71). In concert with a lytic transglycosylase activity, MepA
was described to be responsible for the degradation of the peptidoglycan during
autolysis (87).
The main class of autolytic peptidoglycan hydrolases in E. coli seems to be the lytic
transglycosylase family. With the addition of the new members as described in this
thesis, this enzyme family almost has outgrown that of the penicillin binding
proteins. The lytic transglycosylases are discussed in more detail below.
Function of the E. coli hydrolases
It becomes apparent from the listing of current state of knowledge on the above
mentioned hydrolases that although a lot of effort has been put in the
characterization of each of these enzymes, information as to the function of most (if
not all) of them is lacking. Moreover, not one hydrolase has been identified so far
that is absolutely essential for growth. This is very puzzling and makes one wonder
why E. coli would keep such a large arsenal of potentially dangerous enzymes
around if their function is not essential.
The hydrolases have been proposed to act in the overall peptidoglycan metabolism
as spacemaker enzymes, but one may assume that this would be an essential
function and that the deletion of hydrolases involved in this process would impair
cellular growth. Furthermore, a process where one would definitely expect
hydrolases to be involved is cell division and splitting of the septum. In contrast to
gram-positive bacteria, no deletions in autolytic enzymes have been described that
cause a defect in cell separation.
Three explanations may be envisaged for this paradoxical large number of
hydrolases without an essential function. 1. The high redundancy of the hydrolase
reflects a back-up mechanism and various enzymes can substitute for each others
function. Proof for this hypothesis awaits the construction of deletion mutants in
which all of the hydrolases belonging to one class are inactivated. 2. The function of
these enzymes may not be essential for growth under optimal laboratory conditions.
One of the processes that the hydrolases are often discussed to be involved in is
turnover of the peptidoglycan. The process of turnover has been long recognized to
be present in certain gram-positive bacteria that release large amounts of
peptidoglycan breakdown products into the medium (32). Turnover in E. coli has
long escaped attention due to the presence of the outer membrane and the highly
efficient recycling which results in a loss of only 6-8% of the 50% of peptidoglycan
that is turned over per generation (49, 51). Clearly the process of turnover involves
hydrolytic activities and although it is not essential for growth under laboratory
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conditions, it may be of vital importance for in vivo growth under conditions where
the supply of nutrients is limited.
The third explanation may be that the truly essential hydrolases have not been
identified yet. In this respect the presence of further, uncharacterized homologues
that were identified from genomic sequencing projects certainly deserves further
attention. Some of these uncharacterized homologues belong to the already largest
family of peptidoglycan hydrolases in E. coli, the lytic transglycosylases.
The lytic transglycosylases
The first identification of an E. coli peptidoglycan hydrolytic activity that caused the
formation of disaccharidepeptide breakdown products, was reported in 1972 (57).
Although this activity seemed to cleave the same bond as is cleaved by lysozyme,
the resulting muropeptide products differed in that they did not contain a reducing
end group. The enzyme that was responsible for this activity was purified by Höltje
in 1975 and proved to be a novel type of peptidoglycan hydrolase of unique product
specificity (69). Indeed the enzyme proved to cleave the b -1,4-glycosidic bond
between the N-acetylmuramic acid and the N-acetylglucosamine residues of the
glycan strands but in addition it was shown to catalyze an intramolecular
glycosyltransferase reaction, resulting in the formation of an anhydro bond between
the C6 and C1 of the muramic acid residue (Fig. 5). The enzyme was called lytic
transglycosylase and later the prefix "soluble" was added, to distinguish it from the
membrane-derived activity that is described below. Based on its molecular weight of
70 kDa and in order to distinguish it from further members of the family that were
later identified, it will be denoted Slt70 in the remainder of this thesis. The enzyme
was shown to have a pH optimum of 4.5 and an isoelectric point of 5.2 and was later
described to have affinity for polyanionic molecules and in fact, even to be strongly














































FIG. 5. Reaction catalyzed by the lytic transglycosylases. The b -1,4-glycosidic bond
between the N-acetylmuramic acid and the N-acetylglucosamine residues is
cleaved and the released muropeptide contains an intramolecular 1,6-anhydro
bond.
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It took 14 years before the gene coding for Slt70 was cloned, and in the meantime a
second transglycosylase activity had been described to be present in E. coli. This
second activity was derived from the membrane fraction and had an apparent
molecular weight of 35 kDa (84, 113). For some time it was unclear whether the 70
kDa enzyme was in fact a precursor of the 35 kDa enzyme but the separate identity
could be clearly demonstrated by immunological methods and peptide mapping.
The cloning of the slt gene by Betzner and Keck (12), allowed further
characterization of the Slt70 protein. It could be shown that the gene mapped next to
the tryptophan repressor at 99.7 minutes on the E. coli chromosome.
Using the cloned gene, the in vivo activity of Slt70 could be studied. Biochemical
characterization had already clarified that in vitro the enzyme was able to totally
degrade the peptidoglycan down to monomeric 1,6-anhydromuropeptides and that
it did so in an exoenzymatic way, starting from the N-acetylglucosamine end of the
glycan strands (6). The presence of the gene in a high-copy number plasmid resulted
in an overproduction of about 30 fold, which did have some effect on the viability of
the cells but did not result in the massive lysis that might have been expected from
the in vitro activity (12).
Determination of the sequence of the slt gene revealed that it codes for a protein of
645 amino acids, the first 27 of which constitute an N-terminal signal sequence (34).
Cloning of the gene into an expression vector allowed the protein to be
overproduced at high levels and it was observed that even a 250-fold
overproduction did still not cause lysis of the culture. This observation implied that
the activity of Slt70 must in some way be regulated. It had already been shown that
in vivo, the activity of the lytic transglycosylase was controlled by the stringent
response (11). This stringent response is induced by amino acid deprivation and is
one of the few established regulatory mechanisms that are known to control the
activity of autolytic enzymes, another one being regulation by the heat shock
response (168). Using synchronized cultures, it was furthermore determined that the
activity of Slt70 was not regulated in a cell-cycle dependent way, in contrast to PBP4
(54). Based on studies on the localization of Slt70 in the bacterial envelope, using
immunogold labeling techniques, it was postulated that the peptidoglycan displays
only a limited number of binding sites for Slt70, thus imposing some kind of
topological control (161). Other mechanisms may involve allosteric regulation by
other proteins or more general restriction of access to the vulnerable parts of the
substrate.
The high overproduction of the protein allowed purification in quantities large
enough for crystallographic studies, which resulted in the elucidation of the first
structure of a bacterial peptidoglycan hydrolase (see below) (135).
Further characterization of the membrane bound transglycosylase (Mlt) proved to be
quite an ordeal. Using antiserum that was raised against purified protein, a gene
that presumably encoded the membrane bound transglycosylase was isolated (35).
Unfortunately, sequencing of this gene revealed that it was identical to the unrelated
msbB gene, which had been described as a multicopy supressor of htrB, a gene that is
required for growth at high temperatures (82). Based on the purification of a second
soluble transglycosylase of which the molecular weight corresponded to that of Mlt,
the 35kDa lytic transglycosylase was proposed not to be membrane bound afterall
(35). An N-terminal sequence of the purified 35kDa soluble lytic transglycosylase
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(Slt35) could be obtained and on basis of this information the gene could be cloned,
as described in Chapter 3 of this thesis.
It was recently reported that apart from Slt70 and Slt35 a third activity is present
which again was proposed to be membrane bound (155). The gene coding for this 38
kDa membrane bound transglycosylase (MltA) was recently cloned and was
reported to encode a lipoprotein, thus confirming the membrane localization (105).
No detailed information on the gene product is available yet, but its sequence is
unrelated to that of either of the two other transglycosylases and preliminary
evidence suggest that, in contrast to Slt70 and Slt35, MltA is able to degrade glycan
strands that do not carry peptides (133).
The presence of three lytic transglycosylases in E. coli seems not to be the end of the
story as further members of this family could be identified, based on the structure of
Slt70. The identification of these new members of the lytic transglycosylase family is
described in this thesis.
Structure of the 70 kDa soluble lytic transglycosylase
The first electron density map of Slt70 that was produced, revealed a very peculiar
feature: in the middle of the protein a big hole seemed to be present. The dimensions
of this hole were at first a cause of some skepticism, but the fact that its presence
could be confirmed by means of electron microscopy was very convincing (Fig. 6).
The 3-dimensional structure of Slt70 is shown in Fig. 7. The protein is build up of
three domains (146). The N-terminal domain and the second so-called linker domain
together form a closed ring, often referred to as “the doughnut”. These domains are
completely a -helical comprising 27 helices in total that are arranged in a superhelical
fashion. The third, C-terminal, domain lies on top of the ring-domain. This domain
is also almost totally alpha-helical and only contains three very short stretches of b -
sheet.
FIG. 6. Negatively stained electron micrograph of Slt70 molecules. The presence of
the doughnut shaped protein molecules can be detected.
A very remarkable finding was the structural resemblance of the C-terminal domain
of Slt70 to the lysozyme fold. Although Slt70 hydrolyses the same bond in the
peptidoglycan as the lysozymes, no significant sequence homology had been
detected between the sequences of both classes of enzymes (34).
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FIG. 7. Molscript-generated ribbon representation of the structure of Slt70, viewed
from the front and the side (right). The C-terminal domain is depicted in a dark
shading. The position of the active site is indicated by the arrow.
FIG. 8. Comparison of the fold of goose-lysozyme on the left and the C-terminal
domain of Slt70 on the right. The position of the active site glutamic acid is
indicated in both structures. This lysozyme fold is characterized by the presence of
an extended central binding groove that divides the structure into two lobes. These
features are also clearly recognizable in the C-terminal domain of Slt70. In the
active site of the C-terminal domain, the bound inhibitor bulgecin A is depicted
(147).
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However, an in depth comparison of the structure of the C-terminal domain of Slt70
with the structures of phage-type, hen egg-white type and goose-type lysozyme,
showed that the overall fold and especially the architecture of the active site is
strongly conserved between the C-terminal domain of Slt70 and the goose-type
lysozymes in particular (Fig. 8). Based on these findings the C-terminal domain of
Slt70 was proposed to define a new class of lysozymes (145).The most striking
difference between the lysozyme-like domain of Slt70 and the lysozymes turned out
to be the lack of an aspartate in the proposed active site of Slt70. Based on the
structure of hen egg-white lysozyme, which was the first structure of an enzyme to
be determined, a mechanism for the cleavage of the b -glycosidic bond was proposed
that involved two amino acid residues in the active site (127) (Fig. 9). Donation of a
proton from the “catalytic” glutamic acid to the glycosidic oxygen, causes the b -
glycosidic bond to be cleaved and results in the formation of a oxocarbonium ion
intermediate. The negative charge of second “catalytic” residue, an aspartate,
stabilizes this intermediate, allowing a water-molecule to diffuse into the active site
and to attack the C1-carbon. In the product of this so-called double displacement
reaction, the configuration at the C1 is conserved, and this type of mechanism is
















































































FIG. 9. Comparison of the proposed catalytic mechanisms of lysozyme and the
soluble lytic transglycosylase. The first step involves cleavage of the b -glycosidic
bond by donation of a proton from the catalytic glutamic acid. In the case of
lysozyme, the resulting oxocarbonium intermediate is stabilized by the negatively
charged aspartate, allowing a water molecule to approach and attack the positively
charged intermediate. In the proposed mechanism for Slt, an intramolecular attack
of the C6 oxygen results in the formation of a 1,6-anhydro bond.
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Over the years it has become clear that the lysozyme mechanism is not as dogmatic
as it is often presented in biochemistry textbooks. In the structurally well-studied
lysozyme of phage T4, the active site does also contain a glutamic acid and an
aspartate residue at a position equivalent to the catalytic residues of hen egg-white
lysozyme (164). However, it was shown that the proposed catalytic aspartate can be
replaced with a cysteine, without causing full loss of activity, suggesting the
involvement of a covalent intermediate in the mechanism of this lysozyme (56).
Recent evidence suggests that the mechanism in this case is a single-displacement
reaction with inversion of configuration at C1. An astonishing observation was that
by substitution of a single amino acid residue, the mechanism could be converted
from an inverting to a retaining one (95).
The structure of goose lysozyme revealed that neither of the two aspartates that are
present in the active site of that enzyme is close enough to be directly involved in the
catalytic mechanism, and based on this observation the catalytic glutamic acid was
proposed to be responsible for both the cleavage of the scissile bond and
stabilization of the oxocarbonium intermediate (163). Another possible explanation
for the apparent inessentiality of the aspartate is so-called substrate-assisted
catalysis. It was discussed that the presence of carboxylate groups on certain
substrates, such as the peptidoglycan of Micrococcus luteus could be responsible for
the enhanced activity of goose egg-white lysozyme and of an aspartate-alanine
mutant of hen egg-white lysozyme towards these substrates (110). The results of
other studies suggest the possible contribution of the acetamide group of the
muramic acid residue to the stabilization of the oxocarbonium ion intermediate.
Especially in the case of hevamine, a glycosyl hydrolase of plant origin that
possesses both chitinase and lysozyme activity , strong evidence has been obtained
for the participation of this acetamido group in the reaction mechanism (144). Based
on the structure of Slt70 with a specific inhibitor, the possible contribution of the
acetamido group in the reaction mechanism was also discussed as a potential
explanation for the absence of an aspartate (147).
Slt70 is the target of bulgecin
The first b -lactam of bacterial origin was isolated by Imada and coworkers from the
culture broth of Pseudomonas mesoacidophila (73). Apart form this b -lactam, which
was called sulfazecin, these bacteria were shown to produce another metabolite, that
was not an antibiotic in its own right but which enhanced the lytic effects of
sulfazecin and other b -lactams that preferentially inhibit PBP3 (72). Based on the
formation of characteristic bulges by the combined action of this metabolite and b -
lactams, it was called bulgecin (116). The structure of bulgecin A is depicted in
Fig. 9.
When an slt deletion mutant was treated with PBP3 specific b -lactams, similar
bulges were produced, which led Templin to propose that Slt70 is the target of
bulgecin (143). Although it is surprising that an inhibitor of a autolytic hydrolase
would result in an enhanced lysis, specific inhibition could indeed be demonstrated.
Based on the kinetics of inhibition, bulgecin was described to be an non-competitive
inhibitor (143). This assertion was refuted by the determination of the structure of
the complex between Slt and bulgecin, which rather suggested a mimicking or the
oxocarbonium intermediate by the inhibitor (147). Bulgecin was shown to be located
in the active site, where it occupies sugar binding sites C an D. In this arrangement a
close interaction of the hydroxymethyl group of the proline moiety of bulgecin with
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the catalytic glutamic acid could be observed, which explains the failure of













FIG. 9. Structure of bulgecin A. In the structures of bulgecins B and C, the taurine
moiety is replaced by a b -alanine and hydroxyl group, respectively.
Recently, the structures of complexes of goose-type lysozyme with bulgecin and the
c-type lysozyme of the rainbow trout with bulgecin have become available (80, 81).
The binding mode of bulgecin in the active site of these lysozymes proved to be
comparable to that in the active site of Slt70. Especially the inhibition of a c-type
lysozyme, which was inferred from the binding to the active site of the rainbow
trout lysozyme, is surprising as another c-type lysozyme, that of hen egg-white, was
observed not to be inhibited by this glycopeptide (our unpublished observations).
Possible function of the lytic transglycosylases
In spite of twenty years of research on Slt70, its physiological function has remained
obscure. The fact that the gene coding for Slt70 can be deleted does not indicate an
important function for the enzyme (143). The same argument holds true for both
membrane-bound transglycosylases (33, 105). On the other hand, inhibition of the
activity of Slt70 shows a clear biological effect under circumstances where the
peptidoglycan metabolism is unbalanced. A possible explanation for this
observation may be that Slt70 in an inactive form sits on the end of the sugar strand
and as such prevents the access of other processive autolysins. Inhibition with
bulgecin would then cause Slt70 to fall of, rendering the downstream sugar strand
vulnerable.
Based on the reported affinity of Slt70 for PBP3 and PBP7 (132), the existence of a
peptidoglycan-synthesizing holoenzyme was postulated. Two of these holoenzymes
were discussed to present in E. coli, one involved in elongation and the other in
septum formation (66). The function of these putative holoenzymes was integrated
in the three-for-one model. It is however hard to reconcile the proposed function of
Slt70 in such a septation holoenzyme with the fact that it is not essential for growth
nor division of the bacterial cell.
A feature of Slt70 and the other lytic transglycosylases of which the biological
relevance has often been discussed, is the specific production of 1,6-
anhydromuropeptides. It was assumed that formation of the 1,6-anhydro bond
serves to preserve energy that can be used in recycling (69). However, there is
evidence that the 1,6-anhydromuropeptides are not directly reincorporated into the
peptidoglycan during the recycling process. Rather they are further degraded by the
action of a N-acetylglucosaminidase and amidase after which the released peptide is
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taken up by the Opp permease and reintegrated in the peptidoglycan biosynthetic
pathway (49-51).
Based on the fact that the bacteriophage lambda lysozyme is also known to produce
muropeptides of the 1,6-anhydro form (142), one could argue that formation of this
1,6-anhydrobond only reflects a variation in the lysozyme mechanism, which is not
physiologically relevant. On the other hand, several biological important effects
have been attributed to these muropeptides, as described below. The question as to
whether the production of 1,6-anhydro-muropeptides was selected specifically to
elicit these effects, or that the affected systems have been selected to respond to these
specific muropeptides is probably a chicken and egg question.
As the muramic acid ends of all of the sugar strands present in E. coli peptidoglycan
carry an 1,6-anhydro bond (70), the question arises as to which transglycosylase is
responsible for the formation of this bond and what the physiological relevance of
this phenomenon is. These 1,6-anhydro ends could be the products of trimming of
the glycan strand after it has been incorporated into the peptidoglycan layer.
Alternatively, the 1,6-anhydro ends could be produced during the cleaving of the
newly synthesized strand from the lipid precursor.
Biological activities of 1,6-anhydromuropeptides
Signaling molecules
Recently it has been described that apart from the above mentioned pathway, a
second system exists that is involved in the recycling of peptidoglycan breakdown
products (76, 122). This recycling mechanism involves the direct uptake of 1,6-
anhydromuropeptides into the cytoplasm, by means of the AmpG transporter. In the
cytoplasm the muropeptides are further digested by the AmpD amidase and the
released peptides are ligated to the precursor molecules by the murK protein. In a
number of gram-negative bacteria, such as Enterobacter cloacae and Citrobacter
freundii, this recycling pathway was found to be connected to a signaling mechanism
that controls expression of the chromosomally encoded b -lactamase AmpC. It
appeared that if 1,6-anhydromuropeptides are produced in excess, this surplus is
interpreted as a signal for the presence of b -lactam antibiotics. This then results in
induction of the ampC gene, presumably by direct interaction of the 1,6-
anhydromuropeptides with the transcriptional regulator AmpR. As E. coli lacks a
chromosomally encoded b -lactamase but does possess an AmpG and AmpD
encoding gene, it has been speculated that this signaling system is more general and
maybe involved in the monitoring of the metabolic state of the peptidoglycan and
regulation of the peptidoglycan biosynthetic and hydrolytic machinery (122).
Virulence factors
The culture supernatants of Bordetella pertussis were found to contain an exotoxin
that had a damaging effect on the ciliated cells of the respiratory epithelium, the
main sites of adhesion of this pathogen (48). After purification of this tracheal
cytotoxin (TCT) it turned out to be a small molecular weight molecule, rather than a
protein toxin (25). Structure elucidation by means of mass spectroscopy showed that
TCT was identical to 1,6-anhydro-muramyltetrapeptide, the main product of the
lytic transglycosylases (24). In contrast to the release of 1,6-anhydromuropeptides by
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E. coli, it was determined that the release of TCT is not caused by lysis of the cells
but rather is the product of turnover of the peptidoglycan during exponential phase
growth (134).
Similar observations have been done for Neisseria gonnorrhoeae. Also this human
pathogen was shown to release a factor that was cytotoxic to ciliated epithelial cells,
in this case those of human fallopian tube tissue. Again, this factor proved to be
identical to 1,6-anhydro-muramyltetrapeptide (109, 111, 140). It thus seems that the
release of these specific muropeptides serves as a first line of attack in the infectious
mechanism of these unrelated bacteria.
The effects of TCT were shown to be mediated through interleukin 1, which is
believed to induce nitric oxide formation, which in turn has been suggested to be
responsible for the damage to the ciliated cells (60, 61, 117). The structure-function
relationship of TCT was studied extensively, resulting in the recent conclusion that
the toxic activity resides within the L-ala-D-glu-m-dap portion of the peptide (106,
107). The specific contribution of the 1,6-anhydro bond to the biological effects is
therefore questionable.
Immune stimulation
The immunostimulatory properties of bacterial cell walls have long been recognized.
It appears that the immune system has selected the most accessible part of the
bacterial cell, which is the envelope, for the detection of bacterial presence.
Freund was the first to put these properties to use and formulated an adjuvant that
consisted of a suspension of heat-killed mycobacteria in oil (42). Later work focused
on the identification of the active component in these cells walls. It appeared that the
peptidoglycan was responsible for the biological effects. Since then the
immunostimulatory properties of peptidoglycan have been described to contribute
to pathophysiology of diverse inflammatory syndromes such as meningitis, arthritis
and septic shock .
The minimal structure of peptidoglycan that was still biologically active was shown
to be muramyl dipeptide (MDP). Since the first synthesis of this peptidoglycan
analogue, hundreds of derivatives have been evaluated for their potential clinical
use (21, 26, 31, 119)as immunostimulants. Studies on the structure-function
relationship of the muramyl peptide derivatives showed that the conformation of
the amino acids is important but also the sugar part contributes to the effects, e.g.
the addition of an N-acetylglucosamine residue enhances the biological effects.
Although a wealth of information is available on the biological effects of these
synthetic analogues, less effort has been put into studying the effects of naturally
occurring muropeptides (1, 2).
The main muropeptides that are liberated during an E. coli infection are the products
of the lytic transglycosylases. We were able to show that these naturally occurring
muropeptides are much more potent than MDP in induction of the expression of the
inflammatory cytokines interleukin-1 (IL1), IL6 and granulocyte-colony stimulating
factor (G-CSF) (30, 31). The induction was even comparable to that of
lipopolysaccharide (LPS), the bacterial molecule that has received the most attention
as an inducer of the immune system (20). Based on these observations it was
hypothesized that the release of 1,6-anhydromuropeptides may contribute to the
pathophysiology of gram-negative septic shock.
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Sleep induction
A very interesting activity of the 1,6-anhydro-muropeptides is their apparent
function in the regulation of sleep. The observation that the cerebrosal spine fluid
taken from sleep-deprived animals could induce sleep in recipient animals,
provided the first indication for the presence of a factor that can induce sleep (37).
As the efforts to isolate this factor from cerebrosal spine fluid failed, another source
was sought and the relative stability of the factor suggested that it may be isolated
from human urine. In a very remarkable effort, Krueger and colleagues were able to
isolate 30 m g of this sleep inducing, or Factor S (FSu), from 5000 (!) liter of human
urine (92). Mass spectrometric analysis showed that Factor S was derived from
bacteria and that the structure was identical to that of the 1,6-anhydro-
muramyltetrapeptide (108). Administration of 1 picomole of the purified factor
displayed the potential to enhance the duration of slow wave sleep (SWS) in rabbits
(93). The sleep inducing potential of muropeptides seems to be dependent on the
conformation of the muramic acid residue. This is demonstrated by the observation
that MDP or lysozyme products carrying a reducing muramic acid residue are far
less potent inducers of SWS than 1,6-anhydromuropeptides (93, 94). Furthermore
the presence of an O-acetyl group on the C6 of the muramic acid residue was also
reported to enhance the somnogenic effect (78). However, a recent report suggests
that the muramic acid moiety is not absolutely essential for sleep-inducing activity
(77).
The connection of a bacterial cell wall constituent with the induction of sleep,
combined with the pyrogenic properties displayed by these muropeptides suggests
the presence of a natural mechanism that induces sleep and fever on detection of
these bacterial products. This mechanism may be part of the general host response
to infection. Indeed it could be shown that during the course of an infection with
S. aureus in a rabbit model, the patterns of sleep change (152). However, the sleep
promoting factor can also be isolated from the urine of non-infected persons, which
suggests that it is derived from normal gut flora and as such may play a more
general role in the control of sleep.
From the analysis of the correlation between the structure of the muropeptides and
the different biological responses, is has become clear that these responses are
elicited by different parts of the molecules. For instance, the variation of the
structure of synthetic muropeptides clearly showed that sleep induction and
pyrogenecity, although both probably mediated through IL-1, are separate activities
which depend on different substructures of the muropeptides (77). The 1,6-anhydro
bond in the N-acetylmuramic acid residue seems to be relevant for some biological
activities, such as sleep-induction, immune stimulation and meningeal inflammation
(22, 31, 93), but unessential for others, such as TCT function.
Focus and outline of the work described in this thesis
The work described in this thesis was aimed at getting a better understanding of the
peptidoglycan hydrolase system of gram-negative bacteria, with a particular focus
on the lytic transglycosylases. As already mentioned in the preceding sections, it is
often overlooked that the active principle of many of the commonly used antibiotics
is the induction of the autolytic peptidoglycan hydrolases. The ability to induce this
system often determines whether an antibiotic is bactericidal or bacteriostatic. A lot
of effort is currently put into the identification of new antibacterials, and the cidal
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effect is one of the most important criteria in the selection of new lead compounds.
However, much less attention is focused on the elucidation of the mechanisms that
are responsible for this cidal effect. As virtually nothing is known about the specific
regulation of the autolytic system, having a better understanding of this system
would be of great benefit to the development of future antibacterials. One may even
envisage that such understanding could eventually lead to rational design of
compounds that directly induce of the autolytic system, and in this way push the
bacterial self-destruction button.
Apart from induction of the peptidoglycan hydrolase system, interfering with it in
an inhibitory way may also be interesting form an antibacterial point of view. It is
unlikely that autolysis is a physiological relevant function and most hydrolases will
have another function in the peptidoglycan metabolism. Although no absolutely
essential hydrolases have been identified yet, one may expect hydrolase activities to
be involved in cellular growth and division. Specific inhibition of these activities
may have a pronounced effect on the growth of the cells and may even lead to the
induction of autolysis by a disturbance of the overall regulatory balance. This latter
assumption is supported by the observation that the inhibition of the major autolytic
activity of E. coli, the 70 kDa soluble lytic transglycosylase (Slt70), actually enhances
lysis. Studying the mechanisms involved in this phenomenon may reveal more
common mechanism of regulation of the peptidoglycan hydrolases.
An opportunity to study this major autolysin from E. coli on a molecular level, has
become available with the elucidation of the 3-dimensional structure. Apart from the
interest in this enzyme as a model system for the function and regulation of
autolysins in gram-negatives., the soluble lytic transglycosylase is also very
interesting from an enzymological point of view. The enzyme shares structural
similarity with the lysozymes, yet is has a different product specificity. Studying this
enzyme may therefore shed light on the general mechanism of the lysozymes.
In Chapter 1, the structural information on Slt70 is used to investigate the active site
and domain-architecture of the protein. Using site-directed mutagenesis, the
proposed active site residues were probed for their possible involvement in the
catalytic mechanism. Furthermore attempt were made to produce the active site
domain as a separate entity thus creating a true bacterial lysozyme. An important
question as to the function of the ring domain was pursued by locking the ring in a
closed conformation.
The second part of this thesis, focuses on the identification of other members of the
lytic transglycosylase family. One more soluble activity was described to be present
in E. coli. Based on the N-terminal amino acid sequence, the gene coding for this
transglycosylase was isolated from a genomic library, as described in Chapter 3.
Chapter 4 and 5 describe another approach to identify new members of the lytic
transglycosylase family. Based on sequence information that was derived from the
structure of Slt70, new lytic transglycosylases could be identified from the genomic
sequence of E. coli and H. influenzae. The cloning and characterization of these is
reported.
The identification and characterization of new lytic transglycosylases, as described
in Chapter 3-5 benefited from the use of zymogram technology. Although so far
mainly used for the study of gram-positive autolysins, this analysis proved to be
very powerful for the analysis of gram-negative hydrolases too. To further develop
the power of this method, it was combined with the methodology of 2D-
electrophoresis and direct spot identification by mass spectroscopy. While
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establishing this method it appeared that not only hydrolases but also peptidoglycan
binding proteins are detected. From an extract of H. influenzae a protein was
identified that proved to be homologous to a periplasmic export factor of E. coli. The
peptidoglycan-binding properties of this protein were studied.
In the third part of this thesis an attempt is made to shed some light on the
physiological function of the lytic transglycosylases. In chapter 8 a general principle
of bacterial transport is hypothesized, based on the identification of lytic
transglycosylase homologs in several export systems and a survey of evidence from
the literature.
One possible role of the lytic transglycosylases lies in their ability to produce 1,6-
anhydromuropeptides. Chapter 9 describes the results of a study of the
immunostimulatory effects of 1,6-anhydromuropeptides  in vivo, in an animal model
of gram-negative septic shock.
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